Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers

13 Apr 20264 min read0 viewsINTERVENTIONAL Trial

GIST

RECRUITING · INTERVENTIONAL · TREATMENT study · Advanced Malignant Solid Neoplasm · Phase 1 · Enrollment 35 · Sponsor: National Cancer Institute (NCI)

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Oncology on 13 Apr 2026. The item focuses on Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers. Open the detail page to review the full original feed content.